Thomson Medical Group Limited (SGX:A50)

Singapore · Delayed Price · Currency is SGD

0.0530

-0.0010 (-1.85%)

Sep 3, 2026, 10:07 AM SGT

-10.17% (1Y)

Market Cap	1.43B -8.5%
Revenue (ttm)	426.59M -6.4%
Net Income	-29.70M
EPS	-0.00
Shares Out	26.44B
PE Ratio	n/a
Forward PE	230.32
Dividend	n/a
Ex-Dividend Date	n/a

Volume	68,400
Open	0.0540
Previous Close	0.0540
Day's Range	0.0530 - 0.0540
52-Week Range	0.0520 - 0.0670
Beta	0.29
Analysts	Buy
Price Target	0.07 (+32.08%)
Earnings Date	Aug 27, 2026

About Thomson Medical Group

Thomson Medical Group Limited, an investment holding company, is engaged in operating hospitals and clinics and provision of healthcare services for women and children in Singapore, Malaysia, and Vietnam. The company owns and operates the Thomson Medical Centre, as well as a network of medical clinics and facilities. The company also offers urgent care services, such as basic resuscitation, ECG, vaccinations, IM/IV fluid and IV antibiotic administration, surgeries and procedures, wound care and stitching, and X-ray and basic laboratory tests; h... [Read more]

Industry Medical Care Facilities

Sector Healthcare

Founded 1979

Employees 2,185

Stock Exchange Singapore Exchange

Ticker Symbol A50

Full Company Profile

Financial Performance

In fiscal year 2026, Thomson Medical Group's revenue was 426.59 million, a decrease of -6.35% compared to the previous year's 455.53 million. Losses were -29.70 million, -37.57% less than in 2025.

Financial Statements

Analyst Summary

According to 2 analysts, the average rating for A50 stock is "Buy." The 12-month stock price target is $0.07, which is an increase of 32.08% from the latest price.

Price Target

$0.07

(32.08% upside)

Analyst Consensus: Buy

Stock Forecasts